Life Science Company News

Results 381 - 400 out of 500 displayed.

By: PR Newswire Association LLC. - 04 Dec 2024

Viral Vaccines Market to be Worth $64.18 Billion by 2031 - Exclusive Report by Meticulous Research®

By: PR Newswire Association LLC. - 04 Dec 2024

Global IVD Reagents Market to Reach USD 55.3 Billion by 2029: Key Drivers and Trends Unveiled | Valuates Reports

By: PR Newswire Association LLC. - 04 Dec 2024

RNA Sequencing: Transforming Genomics and Shaping Future Markets

By: PR Newswire Association LLC. - 04 Dec 2024

Evommune Presents Positive Clinical Results of its MRGPRX2 Antagonist (EVO756) at the 7th GA²LEN Global Urticaria Forum

By: PR Newswire Association LLC. - 04 Dec 2024

The Intersection of AI, Medicine, and Stocks: A New Era of Opportunities Issued on behalf of Avant Technologies Inc.

By: PR Newswire Association LLC. - 04 Dec 2024

LifeSpeak Inc. Expands Weight Management Libraries and Wellbeing Solutions with New GLP-1 Resources to Help Employers and Health Plans Maximize Their Investment in GLP-1s

By: PR Newswire Association LLC. - 04 Dec 2024

New NP clinical director role a win for residents, their loved ones and staff in long-term care

By: PR Newswire Association LLC. - 04 Dec 2024

Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943

By: GlobeNewswire - 04 Dec 2024

Related companies: Vincerx Pharma, Inc.

ImPact Biotech Presents Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at SUO 2024

By: GlobeNewswire - 04 Dec 2024

Related companies: Impact Biotech, LLC | ImPact Biotech

8 Years Survival with Complete Cure for a Patient with Advanced Liver Cancer Being Treated with Can-Fite’s Namodenoson Drug

By: GlobeNewswire - 04 Dec 2024

Related companies: Can-Fite BioPharma Ltd

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers

By: GlobeNewswire - 04 Dec 2024

The Multiple Myeloma Research Foundation (MMRF) Announces the First Patient Enrolled in its Horizon Clinical Trials Program to Accelerate the Identification of Optimal Treatment Strategies for Multiple Myeloma

By: GlobeNewswire - 04 Dec 2024

Related companies: Multiple Myeloma Research Foundation, Inc.

EyePoint Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYU™ for the Treatment of Wet Age-Related Macular Degeneration

By: GlobeNewswire - 04 Dec 2024

Related companies: EyePoint Pharmaceuticals, Inc.

Health Care Resource Centers Debuts Refreshed Logo and Brand Identity as a BayMark Health Provider

By: GlobeNewswire - 04 Dec 2024

Atea Pharmaceuticals Announces Positive Results from Phase 2 Study of Bemnifosbuvir and Ruzasvir Regimen for Treatment of Hepatitis C Virus (HCV)

By: GlobeNewswire - 04 Dec 2024

Related companies: Atea Pharmaceuticals, Inc.

Hop Valley Brewing Co. and Portland Trail Blazers Partner to Launch New Hop Box Bar at Moda Center

By: GlobeNewswire - 04 Dec 2024

Related companies: Tilray Inc.

Coloplast divests core Skin Care product portfolio

By: GlobeNewswire - 04 Dec 2024

Related companies: Coloplast A/S

Plus Therapeutics to Showcase ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

By: GlobeNewswire - 04 Dec 2024

Related companies: Plus Therapeutics, Inc.

Quipt Home Medical Corp. to Announce Fiscal Fourth Quarter and Full Year 2024 Financial Results on December 16, 2024

By: GlobeNewswire - 04 Dec 2024

Related companies: Quipt Home Medical, Corp.

Results 381 - 400 out of 500 displayed.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Enhance your business development with Biotechgate

Try for free »